Aleš Kroutil

Platinum(IV) Complex with Adamantylamine as Nonleaving Amine Group:  Synthesis, Characterization, and in Vitro Antitumor Activity against a Panel of Cisplatin-Resistant Cancer Cell Lines

F. Žák, Jaroslav Tuřánek, Aleš Kroutil et al. · Journal of Medicinal Chemistry · 2003 · 73 citations

Engineering, Nonleaving Amine Group, New Platinum +16

High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro

Alois Kozubı́k, Viktor Horváth, Lenka Šindlerová et al. · Biochemical Pharmacology · 2004 · 54 citations

Medicine, Cancer Treatment, Radiation Oncology +6

New platinum(IV) complex with adamantylamine ligand as a promising anti-cancer drug: comparison of in vitro cytotoxic potential towards A2780/cisR cisplatin-resistant cell line within homologous series of platinum(IV) complexes

Jaroslav Tuřánek, Andrea Kašná, Dana Záluská et al. · Anti-Cancer Drugs · 2004 · 40 citations

Medicinal Chemistry, Promising Anti-cancer Drug, Anti-tumor Potency +15

Preclinical anti-tumor activity of a new oral platinum(IV) drug LA-12

Petr Sova, A. Mistr, Aleš Kroutil et al. · Anti-Cancer Drugs · 2005 · 32 citations

Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells

Viktor Horváth, Olga Vondálová Blanářová, Lenka Šindlerová et al. · Gynecologic Oncology · 2005 · 31 citations

Medicine, Molecular Biology, Cancer Treatment +5